Biotech

All Articles

8 months after a $213M fundraise, gene publisher Volume makes cuts

.After raising $213 million in 2023-- some of the year's biggest personal biotech rounds-- Volume Bi...

BioMarin creates officer crew with biotech veterinarians-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of substantial management hirings, shootings and...

Biopharma Q2 VC attacked highest degree because '22, while M&ampA slowed down

.Financial backing backing in to biopharma cheered $9.2 billion around 215 handle the 2nd one-fourth...

Bicara, Zenas look for IPOs to drive late-phase properties towards market

.Bicara Therapeutics as well as Zenas Biopharma have provided fresh motivation to the IPO market wit...

Genentech to close cancer immunology research study department

.Genentech will certainly close its own cancer immunology investigation division, and unit head and ...

Kezar goes down sound lump however to confirm its own really worth in period 1 trial

.Kezar Lifestyle Sciences is actually losing its own dim stage 1 solid lump medicine as the biotech ...

Acelyrin goes down izokibep, dismisses 3rd of team

.Regardless of izokibep maintaining its own newly found winning touch in the clinic, Acelyrin is no ...

Rivus' stage 2 obesity-related heart failure test attacks endpoint

.Rivus Pharmaceuticals has actually plumped up the leads of its fat-busting, muscle-sparing drug pro...

Ovid standstills preclinical job, IV program after soticlestat fall short

.Ovid Rehab already showed last month that it was actually trimming its headcount as the business na...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Seaport

.Eli Lilly has actually opened a $700 million R&ampD facility in the Boston ma Port, increasing its ...